Home / Montelukast / Canada
CA ATC R03DC03 · updated 2 Nov 2026
Montelukast shortage in Canada
Is there a Montelukast shortage in Canada?
Yes. As of 2 Nov 2026, 8 Montelukast products are reported short in Canada, the first since 18 Apr 2019. The company estimate for the return is 31 Dec 2026 (latest 30 Jun 2027). Main reason: other.
Also short in United States, France, Italy, Spain, Ireland, Austria, Belgium, Czechia, Norway, Sweden, Japan, New Zealand. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MONTELUKAST (30) | SANIS HEALTH INC | 18 Apr 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MONTELUKAST (30) | SANIS HEALTH INC | 19 Apr 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-MONTELUKAST (30 (blister pack)) | JAMP PHARMA CORPORATION | 12 May 2022 | not given | Other Other (Please describe in comments) |
| CA | JAMP-MONTELUKAST (30 (blister)) | JAMP PHARMA CORPORATION | 31 May 2022 | not given | Other Other (Please describe in comments) |
| CA | NAT-MONTELUKAST (30 UD BLS) | NATCO PHARMA (CANADA) INC | 30 Apr 2024 | 31 Dec 2026 | Other Other (Please describe in comments) |
| CA | NAT-MONTELUKAST (30 UD BLS) | NATCO PHARMA (CANADA) INC | 30 Apr 2024 | 31 Dec 2026 | Other Other (Please describe in comments) |
| CA | NAT-MONTELUKAST (30) | NATCO PHARMA (CANADA) INC | 1 Jul 2025 | 30 Jun 2027 | Other Other (Please describe in comments) |
| CA | APO-MONTELUKAST (30 BLS) | APOTEX INC | 1 Sep 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.